• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 553

Algal oil (40% docosahexaenoic acid) derived from Schizochytrium sp.

Intended Use: For use as an ingredient in preterm and term infant formula at a maximum use level of 1.25% of dietary fat (maximum of 0.5% of total fat as docosahexaenoic acid).
Basis: Scientific procedures
Notifier: DSM Nutritional Products
Notifier Address: 6480 Dobbins Road, Columbia, Maryland 21045
Date of filing: Dec 23, 2014
GRAS Notice (releasable information): GRN 553 (in PDF) (12.9 MB)
Date of closure: Jun 19, 2015
FDA's Letter: FDA has no questions; some uses may require a color additive listing